• Home
  • Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.

Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.

Author List
Mahajan D, Miller C, Hirose K, McCullough A, Yerian L
Publication
Journal of hepatology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/263460621
Publication Year
2008
PubMed ID
18814928
Publication Title
Mahajan D, Miller C, Hirose K, McCullough A, Yerian L. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J Hepatol. 2008 Nov; 49(5):867-70.